Lazard, Inc. to Post Q3 2024 Earnings of $0.49 Per Share, Zacks Research Forecasts (NYSE:LAZ)
Lazard, Inc. (NYSE:LAZ – Free Report) – Equities research analysts at Zacks Research dropped their Q3 2024 EPS estimates for shares of Lazard in a...
Jasper Therapeutics, Inc. (NASDAQ:JSPR) to Post Q3 2024 Earnings of ($1.02) Per Share, Capital One Financial Forecasts
Jasper Therapeutics, Inc. (NASDAQ:JSPR – Free Report) – Capital One Financial upped their Q3 2024 EPS estimates for Jasper Therapeutics in a report released on...
Roth Capital Weighs in on Fortress Biotech, Inc.’s Q3 2024 Earnings (NASDAQ:FBIO)
Fortress Biotech, Inc. (NASDAQ:FBIO – Free Report) – Roth Capital raised their Q3 2024 EPS estimates for shares of Fortress Biotech in a note issued...
Graco Inc. (NYSE:GGG) Expected to Post Q3 2024 Earnings of $0.76 Per Share
Graco Inc. (NYSE:GGG – Free Report) – Equities research analysts at Zacks Research dropped their Q3 2024 earnings estimates for Graco in a report issued...
Northland Capmk Analysts Raise Earnings Estimates for DURECT Co. (NASDAQ:DRRX)
DURECT Co. (NASDAQ:DRRX – Free Report) – Research analysts at Northland Capmk lifted their Q3 2024 EPS estimates for shares of DURECT in a report...
Q3 2024 Earnings Forecast for Caribou Biosciences, Inc. (NASDAQ:CRBU) Issued By HC Wainwright
Caribou Biosciences, Inc. (NASDAQ:CRBU – Free Report) – Investment analysts at HC Wainwright increased their Q3 2024 earnings per share (EPS) estimates for Caribou Biosciences...